A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.

Ji, Miaomiao; Yuan, Ming; Jiao, Xue; Li, Qiuju; Huang, Yufei; Li, Jing; Wang, Guoyun

Ji, Miaomiao; Yuan, Ming; Jiao, Xue; Li, Qiuju; Huang, Yufei; Li, Jing; Wang, Guoyun.

Afiliación

Ji M; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Yuan M; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Jiao X; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Li Q; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Huang Y; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Li J; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Wang G; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.

Gynecol Endocrinol ; 38(2): 164-169, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34749585

Asunto(s)

Adenomiosis; Adenomiosis/complicaciones; Adenomiosis/tratamiento farmacológico; Adenomiosis/patología; Estudios de Cohortes; Dismenorrea/tratamiento farmacológico; Femenino; Hormona Liberadora de Gonadotropina; Goserelina/uso terapéutico; Humanos; Nandrolona/análogos & derivados

Palabras clave

Adenomyosis; GnRH-a; dienogest

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenomiosis Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Gynecol Endocrinol Asunto de la revista: ENDOCRINOLOGIA / GINECOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google